Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | ASPH | Q12797 | 1/20 | 0.46 |
| ▸ | KDM8 | Q8N371 | 1/20 | 0.46 |
| ▸ | CDC7 | O00311 | 1/20 | 0.44 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.44 |
| ▸ | CDK2 | P24941 | 1/20 | 0.44 |
| ▸ | DBF4 | Q9UBU7 | 1/20 | 0.44 |
| ▸ | SCN1A | P35498 | 1/20 | 0.41 |
| ▸ | SCN1B | Q07699 | 1/20 | 0.41 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.41 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.41 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.41 |
| ▸ | FDPS | P14324 | 1/20 | 0.41 |
| ▸ | EGFR | P00533 | 2/20 | 0.40 |
| ▸ | ATP1A1 | P05023 | 1/20 | 0.40 |
| ▸ | ATP1B1 | P05026 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3784547 | 1.00 | KDM4E (0.46) | KDM4EASPHKDM8CDC7CCNE1 | |
| SCHEMBL1845858 | 0.79 | GAA (0.46) | KDM4EASPHKDM8ADRA2AADRA2C | |
| SCHEMBL3786576 | 0.79 | GAA (0.46) | KDM4EASPHKDM8ADRA2AADRA2C | |
| SCHEMBL17985414 | 0.74 | SCN1A (0.49) | KDM4EASPHKDM8SCN1ASCN1B | |
| SCHEMBL2507116 | 0.74 | SCN1A (0.49) | KDM4EASPHKDM8SCN1ASCN1B | |
| SCHEMBL3258293 | 0.73 | FPR2 (0.50) | KDM4EADRA2AADRA2C | |
| SCHEMBL11394003 | 0.71 | LMNA (0.54) | KDM4EASPHKDM8SCN1ASCN1B | |
| SCHEMBL954734 | 0.70 | CHRM2 (0.45) | SCN1AADRA2AADRA2C | |
| SCHEMBL2847032 | 0.69 | LMNA (0.52) | KDM4EASPHKDM8 | |
| SCHEMBL20852553 | 0.69 | FDPS (0.44) | ADRA2AADRA2CADRA1DADRA1AADRA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2101762-B1 | NOVEL 2 -IMIDAZOLES AS LIGANDS FOR TRACE AMINE ASSOCIATED RECEPTORS (TAAR) | HOFFMANN LA ROCHE (CH) | 2011-05-18 | — | — | EP | claimed |
| US-7858653-B2 | 2-imidazoles | HOFFMAN-LA ROCHE INC. (US) | 2010-12-28 | — | — | US | claimed |
| US-20080146634-A1 | 2-IMIDAZOLES | HOFFMANN-LA ROCHE INC. | 2008-06-19 | — | — | US | claimed |
| US-20220280527-A1 | TRACE AMINE ASSOCIATED RECEPTOR 1 AGONISTS AND PARTIAL AGONISTS FOR PAIN TREATMENT | PURDUE PHARMA L.P. (US) | 2022-09-08 | — | — | US | disclosed |
| US-20190201410-A1 | TRACE AMINE ASSOCIATED RECEPTOR 1 AGONISTS AND PARTIAL AGONISTS FOR PAIN TREATMENT | PURDUE PHARMA L.P. (US) | 2019-07-04 | — | — | US | disclosed |
| EP-3463359-A1 | TRACE AMINE ASSOCIATED RECEPTOR 1 AGONISTS AND PARTIAL AGONISTS FOR PAIN TREATMENT | Purdue Pharma LP (US) | 2019-04-10 | — | — | EP | disclosed |
| WO-2017210616-A1 | TRACE AMINE ASSOCIATED RECEPTOR 1 AGONISTS AND PARTIAL AGONISTS FOR PAIN TREATMENT | PURDUE PHARMA L.P. (US) | 2017-12-07 | — | — | WO | disclosed |
| EP-2101762-B1 | NOVEL 2 -IMIDAZOLES AS LIGANDS FOR TRACE AMINE ASSOCIATED RECEPTORS (TAAR) | HOFFMANN LA ROCHE (CH) | 2011-05-18 | — | — | EP | disclosed |
| US-7858653-B2 | 2-imidazoles | HOFFMAN-LA ROCHE INC. (US) | 2010-12-28 | — | — | US | disclosed |
| US-7858653-B2 | 2-imidazoles | HOFFMAN-LA ROCHE INC. (US) | 2010-12-28 | — | — | US | disclosed |
| US-7858653-B2 | 2-imidazoles | HOFFMAN-LA ROCHE INC. (US) | 2010-12-28 | — | — | US | disclosed |
| EP-2101762-A1 | NOVEL 2 -IMIDAZOLES AS LIGANDS FOR TRACE AMINE ASSOCIATED RECEPTORS (TAAR) | F. Hoffmann-Roche AG (CH) | 2009-09-23 | — | — | EP | disclosed |
| WO-2008071574-A1 | NOVEL 2 -IMIDAZOLES AS LIGANDS FOR TRACE AMINE ASSOCIATED RECEPTORS (TAAR) | F. HOFFMANN-LA ROCHE AG (CH) | 2008-06-19 | — | — | WO | disclosed |
| WO-2008071574-A1 | NOVEL 2 -IMIDAZOLES AS LIGANDS FOR TRACE AMINE ASSOCIATED RECEPTORS (TAAR) | F. HOFFMANN-LA ROCHE AG (CH) | 2008-06-19 | — | — | WO | disclosed |
| US-20080146634-A1 | 2-IMIDAZOLES | HOFFMANN-LA ROCHE INC. | 2008-06-19 | — | — | US | disclosed |
| US-20080146634-A1 | 2-IMIDAZOLES | HOFFMANN-LA ROCHE INC. | 2008-06-19 | — | — | US | disclosed |
| US-20080146634-A1 | 2-IMIDAZOLES | HOFFMANN-LA ROCHE INC. | 2008-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190201410-A1 | TRACE AMINE ASSOCIATED RECEPTOR 1 AGONISTS AND PARTIAL AGONISTS FOR PAIN TREATMENT | TAAR1, TAAR5, OPRL1 | KDM4E 3900/4885ASPH 2194/4885KDM8 2986/4885 |
| US-20220280527-A1 | TRACE AMINE ASSOCIATED RECEPTOR 1 AGONISTS AND PARTIAL AGONISTS FOR PAIN TREATMENT | TAAR1, TAAR5, OPRL1 | KDM4E 3828/4885ASPH 2423/4885KDM8 2723/4885 |
| US-20080146634-A1 | 2-IMIDAZOLES | ABL1, H1-2, IPO4 | KDM4E 915/4885ASPH 1562/4885KDM8 1082/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.